December 18, 2017 / 5:48 AM / a year ago

BRIEF-PAION Grants Exclusive License To Mundipharma For Development And Commercialization Of Remimazolam In Japan

Dec 18 (Reuters) - PAION AG:

* SAID ON SUNDAY GRANTED EXCLUSIVE LICENSE TO MUNDIPHARMA FOR DEVELOPMENT AND COMMERCIALIZATION OF REMIMAZOLAM IN JAPAN

* EUR 1 MILLION UPFRONT PAYMENT TO PAION

* ADDITIONAL REGULATORY AND COMMERCIAL MILESTONE PAYMENTS OF UP TO EUR 25 MILLION

* ROYALTIES RANGING FROM LOW DOUBLE-DIGITS TO OVER 20%

Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below